D37 COPD: DEVELOPMENTAL THERAPEUTICS: A Phase I, Randomised, Double Blind, Placebo Controlled, Study To Assess The Safety, Tolerability And Pharmacokinetics Of Single Inhaled Doses Of The Dual Phosphodiesterase 3/4 (pde3/4) Inhibitor Rpl554 Administered By Nebuliser To Healthy Male Subjects

Saved in:
Bibliographic Details
Published inAmerican journal of respiratory and critical care medicine Vol. 193; p. 1
Main Authors Singh, D, Abbott-Banner, K H, Reid, F, Newman, K
Format Journal Article
LanguageEnglish
Published New York American Thoracic Society 01.01.2016
Online AccessGet full text

Cover

More Information
ISSN:1073-449X
1535-4970